Vimarsana
Biggest News Aggregation in the World

Page 6 - World Dynamix News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from World Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In World Dynamix Today - Breaking & Trending Today

Spherix Global Insights Announces Entry into Asia-Pacific Research with Upcoming IgA Nephropathy Market and Pipeline Assessment in Japan - Vimarsana News

Spherix Global Insights Announces Entry into Asia-Pacific Research with Upcoming IgA Nephropathy Market and Pipeline Assessment in Japan

/PRNewswire/ -- Glomerulonephritis is a major contributor of end-stage renal disease across the globe, with IgA nephropathy (IgAN), also known as Berger's...

Spherix Uncovers Key Differences in the Management of Chronic Kidney Disease Patients in Europe Versus the U.S. - Vimarsana News

Spherix Uncovers Key Differences in the Management of Chronic Kidney Disease Patients in Europe Versus the U.S.

/PRNewswire/ -- The approval of several renal pipeline products in the European market has granted nephrologists new options through which they can manage...

Spherix Uncovers Key Differences in the Management of Chronic Kidney Disease Patients in Europe Versus the U.S. - Vimarsana News

Spherix Uncovers Key Differences in the Management of Chronic Kidney Disease Patients in Europe Versus the U.S.

/PRNewswire/ -- The approval of several renal pipeline products in the European market has granted nephrologists new options through which they can manage...

SGLT2 Inhibitors Are Gaining Momentum in Chronic and Diabetic Kidney Disease, New Spherix Data Reveals - Vimarsana News

SGLT2 Inhibitors Are Gaining Momentum in Chronic and Diabetic Kidney Disease, New Spherix Data Reveals

/PRNewswire/ -- Nephrologists have historically had few options to help slow the progression of kidney disease in their patients – both those with and without...

SGLT2 Inhibitors Are Gaining Momentum in Chronic and Diabetic Kidney Disease, New Spherix Data Reveals - Vimarsana News

SGLT2 Inhibitors Are Gaining Momentum in Chronic and Diabetic Kidney Disease, New Spherix Data Reveals

/PRNewswire/ -- Nephrologists have historically had few options to help slow the progression of kidney disease in their patients – both those with and without...